Use anti-angiogenic strategies to prevent intraplaque angiogenesis studying the effects of the inhibition of bFGF (using K5) and PFKFB3 (using AZ33) on plaque angiogenesis
Angiogenesis is an important contributor to atherosclerotic plaque growth and instability. Clinical ...
Background: Basic fibroblast growth factor (FGF2), is one of the most potent proangiogenic proteins ...
Vascular Endothelial Growth Factor (VEGF) is frequently expressed in several pathological tissues an...
Use anti-angiogenic strategies to prevent intraplaque angiogenesis studying the effects of the inhib...
Unstable atherosclerotic plaques often show plaque angiogenesis which increases the chance of ruptur...
Atherosclerosis is a lipoprotein-driven disease that leads to plaque formation at specific sites of ...
<p>In order to test the anti-angiogenic capacity of new compounds we first synthetized a positive co...
Atherosclerosis is a complex multifactorial disease that affects large and medium-sized arteries. Ru...
Intraplaque angiogenesis increases the chance of unstable atherosclerotic plaque rupture and thrombu...
In this thesis we have investigated different approaches to block intraplaque angiogenesis in athero...
Aberrant angiogenesis contributes to many pathophysiological conditions such as cancer and diabetes ...
During my PhD we have investigated different approaches to block intraplaque angiogenesis in atheros...
Aim Intraplaque angiogenesis is an important contributor to atherosclerotic plaque growth and instab...
In vivo evaluation by optical and PET imaging of IP angiogenesis and validation of PFKFB3 inhibitors...
Aim Intraplaque angiogenesis is associated with progressive and unstable vascular disease. Angiogene...
Angiogenesis is an important contributor to atherosclerotic plaque growth and instability. Clinical ...
Background: Basic fibroblast growth factor (FGF2), is one of the most potent proangiogenic proteins ...
Vascular Endothelial Growth Factor (VEGF) is frequently expressed in several pathological tissues an...
Use anti-angiogenic strategies to prevent intraplaque angiogenesis studying the effects of the inhib...
Unstable atherosclerotic plaques often show plaque angiogenesis which increases the chance of ruptur...
Atherosclerosis is a lipoprotein-driven disease that leads to plaque formation at specific sites of ...
<p>In order to test the anti-angiogenic capacity of new compounds we first synthetized a positive co...
Atherosclerosis is a complex multifactorial disease that affects large and medium-sized arteries. Ru...
Intraplaque angiogenesis increases the chance of unstable atherosclerotic plaque rupture and thrombu...
In this thesis we have investigated different approaches to block intraplaque angiogenesis in athero...
Aberrant angiogenesis contributes to many pathophysiological conditions such as cancer and diabetes ...
During my PhD we have investigated different approaches to block intraplaque angiogenesis in atheros...
Aim Intraplaque angiogenesis is an important contributor to atherosclerotic plaque growth and instab...
In vivo evaluation by optical and PET imaging of IP angiogenesis and validation of PFKFB3 inhibitors...
Aim Intraplaque angiogenesis is associated with progressive and unstable vascular disease. Angiogene...
Angiogenesis is an important contributor to atherosclerotic plaque growth and instability. Clinical ...
Background: Basic fibroblast growth factor (FGF2), is one of the most potent proangiogenic proteins ...
Vascular Endothelial Growth Factor (VEGF) is frequently expressed in several pathological tissues an...
DOI
Add to ORKG